[1] Wu ZF, Lee MS, Wong CS, et al. Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in colon cancer surgery [J]. Anesthesiology, 2018, 129(5):932-941. [2] Longhini F, Bruni A, Garofalo E, et al. Anesthetic strategies in oncological surgery: not only a simple sleep, but alsoimpact on immunosuppression and cancer recurrence [J]. Cancer Manag Res, 2020, 12:931-940. [3] Zhang T, Fan Y, Liu K, et al. Effects of different general anaesthetic techniques on immune responses in patients undergoing surgery for tongue cancer [J]. Anaesth Intensive Care, 2014, 42(2):220-227. [4] Drew SJ. Oral and maxillofacial surgery team anesthesia model and anesthesiaassistant training [J]. Oral Maxillofac Surg Clin North Am, 2018, 30(2):145-153. [5] Kadosawa T, Watabe A. The effects of surgery-induced immunosuppression and angiogenesis on tumour growth [J]. Vet J, 2015, 205(2):175-179. [6] Shaw DM, Merien F, Braakhuis A, et al. T-cells and their cytokine production: The anti-inflammatory and immunosuppressive effects of strenuous exercise [J]. Cytokine, 2018, 104:136-142. [7] Yuki K, Bu W, Xi J, et al. Propofol shares the binding site with isoflurane and sevoflurane on leukocyte function-associated antigen-1 [J]. Anesth Analg, 2013, 117(4):803-811. [8] Xu Y, Pan S, Jiang W, et al. Effects of propofol on the development of cancer in humans[J]. Cell Prolif, 2020, 53(8):e12867. [9] Liu S, Gu X, Zhu L, et al. Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer [J]. Medicine (Baltimore), 2016, 95(49):e5479. [10] Stollings LM, Jia LJ, Tang P, et al. Immune Modulation by Volatile Anesthetics [J]. Anesthesiology, 2016, 125(2):399-411. [11] Yang M, Yu Y, Liu Q. Analgesic effects of sevoflurane and isoflurane on elderly patients with colon cancer and their influences on immunity and postoperative cognitive function [J]. Iran J Public Health, 2019, 48(3):444-450. [12] Lee JM, Han HJ, Choi WK, et al. Immunomodulatory effects of intraoperative dexmedetomidine on T helper 1, T helper 2, T helper 17 and regulatory T cells cytokine levels and their balance: a prospective, randomised, double-blind, dose-response clinical study [J]. BMC Anesthesiol, 2018, 18(1):164. [13] Sobjanek M, Bien E, Zablotna M, et al. Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinoma [J]. Postepy Dermatol Alergol, 2016, 33(4):263-268. [14] Eurelings LEM, Miedema JR, Dalm VASH, et al. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis [J]. PLoS One, 2019, 14(10):e0223897. |